X4 Pharmaceuticals (XFOR) Shares Outstanding (2017 - 2026)
X4 Pharmaceuticals' Shares Outstanding came in at 126.34 million for Q2 2026, compared with 7.41 million a year earlier and unchanged from the prior quarter.
X4 Pharmaceuticals (XFOR) Shares Outstanding (2017 - 2026) Analysis & Trends
For FY2025, X4 Pharmaceuticals' Shares Outstanding was 42.29 million, up 531.0% from FY2024.
- Shares Outstanding carries a five-year compound annual growth rate of 16.1% (FY2020 to FY2025).
- Going back by year, Shares Outstanding was 6.7 million in FY2024 (-96.2%), 177.81 million in FY2023 (+179.9%), 63.53 million in FY2022 (+146.7%) and 25.75 million in FY2021 (+28.3%).
- The Q2 2026 figure represents the highest quarterly Shares Outstanding since Q2 2024.
- Year-over-year, Shares Outstanding increased in two of the last six quarters, with growth averaging 115.3%.
- The fastest year-over-year change in Shares Outstanding over five years came in Q3 2025 (growth of 546.3%), and the weakest in Q3 2024 (a decline of 96.6%).
- Business Quant data shows XFOR's Shares Outstanding at 126.29 million (Q1 2026), 42.29 million (Q4 2025) and 43.27 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.70 Mn |
| 10 | X4 Pharmaceuticals | 366.40 Mn | -332.29 Mn | 7.19 Mn | 126.34 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 126.34 Mn |
| Mar 31, 2026 | 126.29 Mn |
| Dec 31, 2025 | 42.29 Mn |
| Sep 30, 2025 | 43.27 Mn |
| Jun 30, 2025 | 7.41 Mn |
| Mar 31, 2025 | 6.84 Mn |
| Dec 31, 2024 | 6.70 Mn |
| Sep 30, 2024 | 6.70 Mn |
| Jun 30, 2024 | 200.44 Mn |
| Mar 31, 2024 | 199.99 Mn |
| Dec 31, 2023 | 177.81 Mn |
| Sep 30, 2023 | 196.99 Mn |
| Jun 30, 2023 | 168.74 Mn |
| Mar 31, 2023 | 145.97 Mn |
| Dec 31, 2022 | 63.53 Mn |
| Sep 30, 2022 | 83.21 Mn |
| Jun 30, 2022 | 35.44 Mn |
| Mar 31, 2022 | 33.74 Mn |
| Dec 31, 2021 | 25.75 Mn |
| Sep 30, 2021 | 26.61 Mn |
X4 Pharmaceuticals Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=XFOR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "XFOR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=XFOR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();